Alterity Therapeutics Ltd
ATHE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001131343
In the last 90 days, Alterity Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.12M in total; no superinvestor holds it.
Other share classesPRNAF
Q1 2025 vs. Q4 2024
How the institutions holding Alterity Therapeutics Ltd changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 13 | 1 | 12 | 0 |
| Shares | 124.3K | 33 | 241.7K | +117.4K (+94.5%) |
| Value | $415.9K | $109 | $833.9K | +$418.1K (+100.5%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (2)
Institutions that held Alterity Therapeutics Ltd at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Rhumbline Advisers | 130 | $450 | 0.00% |
| JPMorgan Chase & Co | 53 | $184 | 0.00% |
Sold out (2)
Institutions that held Alterity Therapeutics Ltd at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Northwestern Mutual Wealth Management Co | 16 | $53 |
| Coppell Advisory Solutions LLC | 5 | $18 |
Not filed for Q1 2025 yet (1)
Institutions that held Alterity Therapeutics Ltd at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Sugarloaf Wealth Management, LLC | 33 | $109 |